Janus Henderson Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.73M | Hold |
|
|||||
|
2025
Q2 | $1.64M | Sell |
|
|||||
|
2025
Q1 | $45.7M | Buy |
|
|||||
|
2024
Q4 | $48.2M | Sell |
|
|||||
|
2024
Q3 | $60.4M | Buy |
|
|||||
|
2024
Q2 | $52.9M | Buy |
|
|||||
|
2024
Q1 | $55.9M | Sell |
|
|||||
|
2023
Q4 | $214M | Buy |
|
|||||
|
2023
Q3 | $73.5M | Buy |
|
|||||
|
2023
Q2 | $68.4M | Buy |
|
|||||
|
2023
Q1 | $55.4M | Buy |
|
|||||
|
2022
Q4 | $7.97M | Buy |
|
|||||
|
2022
Q3 | $1.45M | Buy |
|
|||||
|
2022
Q2 | $587K | Sell |
|
|||||
|
2022
Q1 | $550K | Buy |
|
|||||
|
2021
Q4 | $682K | Buy |
|
|||||
|
2021
Q3 | $265K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $40.3M | Buy |
|
|||||
|
2017
Q2 | $32.5M | Buy |
|